5 Results for "

LY354740

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "LY354740" in MCE Product Catalog:

  • Targets Recommended:
4
4 Cited Publications
Cat. No.: HY-18941
CAS No.: 176199-48-7
Synonyms: LY354740; Eglumetad
Target:  

mGluR

Research Areas:  

Neurological Disease

Eglumegad (LY354740) is a highly potent and selective group II (mGlu2/3) receptor agonist with IC50s of 5 nM and 24 nM on transfected human mGlu2 and mGlu3 receptors, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-18941C
Synonyms: LY354740 hydrochloride; Eglumetad hydrochloride
Target:  

mGluR

Research Areas:  

Neurological Disease

Eglumegad (LY354740) hydrochloride is a highly potent and selective group II (mGlu2/3) receptor agonist with IC50s of 5 and 24 nM on transfected human mGlu2 and mGlu3 receptors, respectively. Eglumegad hydrochloride protects neurons from NMDA toxicity. Eglumegad hydrochloride has anxiolytic- and antipsychotic-like effects .
loading...
    loading...
Cat. No.: HY-18941B
CAS No.: 176027-90-0
Synonyms: (rel)-LY354740; (rel)-Eglumetad
Target:  

mGluR

Research Areas:  

Neurological Disease

(rel)-Eglumegad ((rel)-LY354740) is a relative configuration of Eglumegad (HY-18941). Eglumegad is a highly potent and selective group II (mGlu2/3) receptor agonist with EC50s of 5 and 24 nM for transfected human mGlu2 and mGlu3 receptors, respectively .
loading...
    loading...
Cat. No.: HY-120699
CAS No.: 1337920-46-3
Target:  

mGluR

Research Areas:  

Neurological Disease

RO5488608 is a negative allosteric metabotropic modulator of glutamate receptor 2/3. RO5488608 inhibits LY354740 (HY-18941)-induced intracellular Ca 2+ release and can be used for study of antidepressant .
loading...
    loading...
Cat. No.: HY-129274
CAS No.: 911114-85-7
Target:  

mGluR

Research Areas:  

Neurological Disease

RO4988546 is a negative allosteric modulator (NAM) that targets metabotropic glutamate receptors 2 and 3 (mGlu2, mGlu3). RO4988546 can reduce the binding of [ 3h]-LY354740 at the positive binding site, while affecting the receptor's G protein coupling and intracellular signaling. RO4988546 can be used in the development of antidepressants and cognitive enhancers .
loading...
    loading...